Amaryl Tablets
PDF Leaflet Revision Date: 27 July 2012
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to diet and exercise for Type 2 diabetes mellitus.
Dosage (summary)
Initial: 1 mg once daily, max: 8 mg.
Onset of Action / Duration
Onset: 30 mins, Duration: 5-8 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- CYP2C9 inducers/inhibitors
- Insulin
- MAO-inhibitors
- ACE-inhibitors
Contraindications
- Hypersensitivity to glimepiride
- Pregnancy
- Breastfeeding
- Impaired liver function
- Type 1 diabetes
Common side effects
- Hypoglycaemia
- Nausea
- Diarrhoea
- Rashes
Counselling Points
- Monitor blood glucose regularly
- Take before meals
- Carry glucose for hypoglycaemia
Serious warnings
- Increased risk of cardiovascular mortality
- Serious hypoglycaemia risk
Important Disclaimer
The Amaryl Tablets professional information leaflet below is the property of Sanofi-Aventis and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
